Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin PK in Chronic Rhinosinusitis
NCT00232154Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of azithromycin in chronic rhinosinusitis (CRS) (2 arms), sponsored by Pfizer. Primary endpoint: Pharmacokinetics of azithromycin in sinus mucosal tissue and plasma up to 3 days. Started Nov 2005; status: completed.
02
Drugs
azithromycin
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT00232154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232154.